Sale!

FMR1 Gene Fragile X Tremorataxia Syndrome Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FMR1 Gene Fragile X Tremor Ataxia Syndrome (FXTAS) Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the FMR1 gene. This gene is crucial because alterations in its structure are associated with Fragile X Tremor Ataxia Syndrome, a condition that affects the nervous system, leading to symptoms such as tremors, problems with movement and balance (ataxia), and cognitive impairments. The test is particularly important for individuals who have a family history of FXTAS or related disorders, as it can provide valuable information for managing and understanding the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the FMR1 gene. Conducting this test at DNA Labs UAE ensures that patients receive reliable results, thanks to the lab’s commitment to high-quality standards and its use of advanced genetic testing technologies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FMR1 Gene Fragile X tremorataxia syndrome Genetic Test

Cost: AED 4400.0

Symptoms and Diagnosis

The FMR1 gene is located on the X chromosome and encodes for a protein called fragile X mental retardation protein (FMRP). Mutations in the FMR1 gene can lead to a variety of disorders, including fragile X syndrome, fragile X-associated primary ovarian insufficiency, and fragile X-associated tremor/ataxia syndrome (FXTAS). FXTAS is a late-onset neurodegenerative disorder that affects both men and women. It is characterized by tremors, ataxia (loss of coordination and balance), cognitive decline, and psychiatric symptoms.

Test Components and Price

  • Test Name: FMR1 Gene Fragile X tremorataxia syndrome Genetic Test
  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

A Clinical History of the patient who is going for FMR1 Gene Fragile X tremor/ataxia syndrome NGS Genetic DNA Test is required. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with FMR1 Gene Fragile X tremor/ataxia syndrome.

Test Details

NGS (next-generation sequencing) genetic testing can be used to diagnose FXTAS by identifying the repeat expansion in the FMR1 gene. This type of testing can also identify carriers of the FMR1 mutation who may be at risk for developing FXTAS or other related disorders. Genetic counseling is recommended for individuals with a family history of FXTAS or other FMR1-related disorders, as well as for those who are considering genetic testing.

Test Name FMR1 Gene Fragile X tremorataxia syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FMR1 Gene Fragile X tremor/ataxia syndrome NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with FMR1 Gene Fragile X tremor/ataxia syndrome
Test Details

The FMR1 gene is located on the X chromosome and encodes for a protein called fragile X mental retardation protein (FMRP). Mutations in the FMR1 gene can lead to a variety of disorders, including fragile X syndrome, fragile X-associated primary ovarian insufficiency, and fragile X-associated tremor/ataxia syndrome (FXTAS).

FXTAS is a late-onset neurodegenerative disorder that affects both men and women. It is characterized by tremors, ataxia (loss of coordination and balance), cognitive decline, and psychiatric symptoms. FXTAS is caused by a repeat expansion in the FMR1 gene, which leads to the accumulation of toxic RNA molecules that damage neurons in the brain.

NGS (next-generation sequencing) genetic testing can be used to diagnose FXTAS by identifying the repeat expansion in the FMR1 gene. This type of testing can also identify carriers of the FMR1 mutation who may be at risk for developing FXTAS or other related disorders.

Genetic counseling is recommended for individuals with a family history of FXTAS or other FMR1-related disorders, as well as for those who are considering genetic testing.